(19)
(11) EP 4 044 956 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.06.2024 Bulletin 2024/23

(45) Mention of the grant of the patent:
17.04.2024 Bulletin 2024/16

(21) Application number: 20891874.8

(22) Date of filing: 25.11.2020
(51) International Patent Classification (IPC): 
A61B 90/00(2016.01)
A61B 17/00(2006.01)
A61L 31/18(2006.01)
 A61K 49/00(2006.01)
A61L 29/18(2006.01)
A61B 8/08(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 8/481; A61B 8/488; A61B 90/39; A61B 2090/3908; A61B 2090/3925; A61B 2090/3966; A61B 2090/3995; A61B 2090/3937; A61B 2090/3954; A61B 2017/00004; A61L 31/18; A61L 29/18
(86) International application number:
PCT/US2020/062272
(87) International publication number:
WO 2021/108587 (03.06.2021 Gazette 2021/22)

(54)

COMPOSITE TISSUE MARKERS DETECTABLE VIA MULTIPLE DETECTION MODALITIES

ZUSAMMENGESETZTE GEWEBEMARKER, DIE ÜBER MEHRERE DETEKTIONSMODALITÄTEN NACHWEISBAR SIND

MARQUEURS TISSULAIRES COMPOSITES DÉTECTABLES PAR L'INTERMÉDIAIRE DE MULTIPLES MODALITÉS DE DÉTECTION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 27.11.2019 US 201962941336 P

(43) Date of publication of application:
24.08.2022 Bulletin 2022/34

(73) Proprietor: View Point Medical, Inc.
Carlsbad, CA 92009 (US)

(72) Inventors:
  • BLAIR, William
    Carlsbad, CA 92010 (US)
  • JONES, Mike
    Carlsbad, CA 92010 (US)
  • MERRITT, John
    Carlsbad, CA 92010 (US)

(74) Representative: Murgitroyd & Company 
165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
WO-A2-01/10302
US-A1- 2016 051 337
US-A1- 2018 021 102
US-A1- 2018 289 444
US-B2- 9 579 077
 US-A1- 2006 293 581
US-A1- 2017 368 209
US-A1- 2018 289 444
US-B1- 6 725 083
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).